Difference between revisions of "ALK inhibitors"

Jump to navigation Jump to search
97 bytes added ,  02:19, 31 December 2019
 
(One intermediate revision by the same user not shown)
Line 10: Line 10:
*[[Inflammatory myofibroblastic tumour]].
*[[Inflammatory myofibroblastic tumour]].
*[[ALK positive lung cancer]].
*[[ALK positive lung cancer]].
*[[ALK translocation renal cell carcinoma]].
*[[ROS1-rearranged non-small cell lung carcinoma]].


==References==
==References==
48,541

edits

Navigation menu